Patents 341show all

  • 164
    A61K - Preparations for medical, dental, or toilet purposes
  • 28
    C07D - Heterocyclic compounds
  • 20
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 17
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 15
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 11
    A61N - Electrotherapy
  • 9
    C07H - Sugars
  • 8
    Y02A - Technologies for adaptation to climate change
  • 2
    A23K - Fodder
  • 2
    A61J - Containers specially adapted for medical or pharmaceutical purposes

Clinical Trials 113show all

38Phase 225N/A23Phase 120Phase 36Other

SEC Filings show all


302
8-K

64
10-Q

20
10-K

3
D

1
S-1

Contact Information

Irvine, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-07-31$27,500,000$27,500,000Equity, Other
2006-05-31Unknown Unknown Other (Paper Filing)

Key Executives

  • Rajesh C. Shrotriya
    Executive Officer, Director
  • Stuart M. Krassner
    Director
  • Luigi Lenaz
    Director
  • Anthony E. Maida
    Director
  • Gilles R. Gagnon
    Director
  • Dolatrai Vyas
    Director
  • Raymond W. Cohen
    Director
  • Kurt A. Gustafson
    Executive Officer
  • Joseph K. Keller
    Executive Officer
  • Joseph W. Turgeon
    Executive Officer
  • Lee F. Allen
    Executive Officer